LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that it is finalizing scheduling for an exclusive live-streamed interview with Hablemos Seguros & Finanzas, a Venezuelan business, finance, and insurance media platform. The interview, expected to occur in the near term, will focus on the Company's healthcare technology development initiatives, telehealth infrastructure efforts, and artificial intelligence applications within healthcare environments, as well as its broader strategy for emerging markets in Latin America.
According to the Company, the discussion will provide an opportunity for management to address recent operational developments, ongoing technology initiatives, and the long-term strategy for building platforms that support patients, providers, and healthcare organizations. Key topics include telehealth infrastructure, healthcare coordination technologies, emergency medical response initiatives, pharmacy integration capabilities, and AI-driven healthcare solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We believe this interview represents a valuable opportunity to communicate LataMed AI’s strategic vision, technology development priorities, and commitment to advancing digital healthcare infrastructure across Latin America. As healthcare systems continue to evaluate technology-enabled models for coordination, access, and efficiency, we remain focused on developing practical solutions designed to support patients, providers, and healthcare organizations in emerging markets."
The Company expects the interview to be live-streamed through the media platform’s digital channels, with a recording made available on the Company's website. The timing and distribution remain subject to final scheduling and production arrangements. The interview is intended for informational purposes only and should not be considered an offer to sell or a solicitation to purchase any securities.
For more information, visit https://latamed.ai or review the Company's filings with the SEC at www.sec.gov.
